Abstract:Despite advances in therapy, malignant melanoma remains a fatal disease. Among several emerging approaches to combat cancer, cold atmospheric pressure plasma (CAP) has shown promising results as a novel antitumor agent in preclinical models so far. The technology mainly relies on the emittance of various reactive oxygen and nitrogen species (ROS/RNS) that are tumor-toxic at high concentrations. Moreover, malignant melanoma has a metabolic dimension that can be targeted by mild starvation.To this end, we invest… Show more
“…As autophagy has been lately shown to be capable of inhibiting cancer stemness in triple-negative breast cancers ( 28 ), and CAP was recently demonstrated with the attributes of triggering autophagy in melanoma cells ( 29 ); we examined whether and how CAP possibly could affect HCC cell autophagy.…”
Hepatocellular carcinomas remain as a global health threat given its high mortality rate. We have previously identified the selectivity of cold atmospheric plasma (CAP) against multiple types of malignant tumors and proposed it as a promising onco-therapeutic strategy. Here, we investigated its roles in controlling hepatocellular carcinoma malignancy and one possible driving molecular mechanism. By focusing on post-translational modifications including acetylation, phosphorylation, and ubiquitination, we identified the crosstalk between EGFR acetylation and EGFR(Tyr1068) phosphorylation and their collective roles in determining LC3B ubiquitination and proposed the EGFR/p-JNK/BIRC6/LC3B axis in CAP-triggered autophagy. Our study not only demonstrated the selectivity of CAP against hepatocellular carcinoma malignancy and confirmed its roles as an onco-therapeutic tool but also opened the horizon of translating CAP into clinics toward a broader scope that included human longevity and anti-aging.
“…As autophagy has been lately shown to be capable of inhibiting cancer stemness in triple-negative breast cancers ( 28 ), and CAP was recently demonstrated with the attributes of triggering autophagy in melanoma cells ( 29 ); we examined whether and how CAP possibly could affect HCC cell autophagy.…”
Hepatocellular carcinomas remain as a global health threat given its high mortality rate. We have previously identified the selectivity of cold atmospheric plasma (CAP) against multiple types of malignant tumors and proposed it as a promising onco-therapeutic strategy. Here, we investigated its roles in controlling hepatocellular carcinoma malignancy and one possible driving molecular mechanism. By focusing on post-translational modifications including acetylation, phosphorylation, and ubiquitination, we identified the crosstalk between EGFR acetylation and EGFR(Tyr1068) phosphorylation and their collective roles in determining LC3B ubiquitination and proposed the EGFR/p-JNK/BIRC6/LC3B axis in CAP-triggered autophagy. Our study not only demonstrated the selectivity of CAP against hepatocellular carcinoma malignancy and confirmed its roles as an onco-therapeutic tool but also opened the horizon of translating CAP into clinics toward a broader scope that included human longevity and anti-aging.
“…Cold atmospheric plasma is composed of varied reactive oxygen and nitrogen species (RONS) including short‐lived species such as hydroxyl radical (OH·), singlet oxygen (O), superoxide (O 2− ), and nitric oxide (NO·), and long‐lived species such as hydrogen peroxide (H 2 O 2 ), ozone (O 3 ), anionic (OONO − ), and protonated (ONOOH) forms of peroxynitrite. Since the first discovery on the anti‐cancer efficacy of CAP in 2007, consecutive efforts have been devoted to investigate its onco‐therapeutic impacts in varied types of cancers with demonstrated efficacies already been proven in, for example, triple negative breast cancers, 201 bladder cancers, 202 prostate cancers, 203 melanomas, 204 and pancreatic cancers 205 . Differential cell death events can be triggered by CAP in a dose‐dependent manner 206 that include, for example, cell cycle arrest, 203 autophagy, 207 apoptosis, 201 ferroptosis, 208 immunogenic cell death (ICD), 209 and necrotic cell death 210 .…”
Section: Cap As An Emerging Tme Editing Toolmentioning
With mounting preclinical and clinical evidences on the prominent roles of the tumor microenvironment (TME) played during carcinogenesis, the TME has been recognized and used as an important onco‐therapeutic target during the past decade. Delineating our current knowledge on TME components and their functionalities can help us recognize novel onco‐therapeutic opportunities and establish treatment modalities towards desirable anti‐cancer outcome. By identifying and focusing on primary cellular components in the TME, that is, tumor‐infiltrating lymphocytes, tumor‐associated macrophages, cancer‐associated fibroblasts and mesenchymal stem cells, we decomposed their primary functionalities during carcinogenesis, categorized current therapeutic approaches utilizing traits of these components, and forecasted possible benefits that cold atmospheric plasma, a redox modulating tool with selectivity against cancer cells, may convey by targeting the TME. Our insights may open a novel therapeutic avenue for cancer control taking advantages of redox homeostasis and immunostasis.
“…Growth factors like insulin-like growth factor (IGF) through activation of IGF receptors (IGFRs) promote the activity of tyrosine kinase and Aκt leading to activation of the mTOR pathway and inhibition of autophagy (Sepúlveda et al 2022 ). Mild starvation also inhibits the mTOR pathway, but the kinase activity remains unaffected leading to acceleration of fusion between the autophagosome and lysosomes (Golpour et al 2022 ). However, when the nutrients are replenished the mTOR pathway is inhibited with a significant reduction of autophagosomes (Golpour et al 2022 ).…”
Autophagy is an explicit cellular process to deliver dissimilar cytoplasmic misfolded proteins, lipids and damaged organelles to the lysosomes for degradation and elimination. The mechanistic target of rapamycin (mTOR) is the main negative regulator of autophagy. The mTOR pathway is involved in regulating neurogenesis, synaptic plasticity, neuronal development and excitability. Exaggerated mTOR activity is associated with the development of temporal lobe epilepsy, genetic and acquired epilepsy, and experimental epilepsy. In particular, mTOR complex 1 (mTORC1) is mainly involved in epileptogenesis. The investigation of autophagy’s involvement in epilepsy has recently been conducted, focusing on the critical role of rapamycin, an autophagy inducer, in reducing the severity of induced seizures in animal model studies. The induction of autophagy could be an innovative therapeutic strategy in managing epilepsy. Despite the protective role of autophagy against epileptogenesis and epilepsy, its role in status epilepticus (SE) is perplexing and might be beneficial or detrimental. Therefore, the present review aims to revise the possible role of autophagy in epilepsy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.